Pantarhei Bioscience BV (PRB) is a limited liability company (Besloten Vennootschap) located in the Netherlands with an innovative concept of drug development in Woman’s Health and Endocrine Cancer. PRB has developed a product pipeline based on its ability to identify novel medical uses of existing molecules, drugs, hormones, biologicals and combinations thereof in these areas of medicine.
The main areas of expertise of PRB are reproductive hormone related treatments and diseases such as contraception, menopausal hormone therapy (MHT) and in oncology breast cancer, prostate cancer and ovarian cancer.
The business concept of PRB is to develop the patented new treatment concepts up to proof-of-concept (PoC) in the human (phase II). Using existing molecules often provides first evidence of safety. The business model is based on solid patent protection, internal project management and external research and development activities. Intellectual property (IP) and data supporting the new treatment concepts are licensed out for completion of clinical development (phase III), regulatory approval and sales and marketing by a licensee/partner.